AVDL News and Press, Avadel Pharmaceuticals plc

2024-06-27 16:11:21 ET More on Avadel Pharmaceuticals plc Avadel Pharmaceuticals: Inflection Point Ahead Avadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly Revolution Avadel Pharma gains during hearing over dispute on FDA approval of a sleep disorder drug...

DUBLIN, June 27, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it is set to join the broad-market Russell 3000 ® Index at the conclusion of the 2024 Russell US Ind...

2024-06-21 09:15:24 ET Summary Jazz Pharmaceuticals plc's suvecaltamide failed in a phase 2b trial for essential tremor, but this is a minor setback for the company and one that should have been expected. The oxybate franchise is performing well despite generic Xyrem and Lumryz co...

2024-06-16 10:38:06 ET Summary Avadel Pharmaceuticals is a small-cap biopharma company headquartered in Dublin, Ireland. The company's primary asset is LUMRYX, which has the potential to be a 'best of breed' compound in a large market. Currently, Avadel is locked in a pivotal ...

2024-05-29 06:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

– 11 accepted abstracts, including new data reiterating satisfaction, preference and clinical benefit of LUMRYZ – – Presentations highlight Avadel’s continued commitment to address gaps in narcolepsy care – DUBLIN, May 22, 2024 (GLOBE NEWSWIRE) -...

DUBLIN, Ireland, May 21, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today the appointment of Naseem Amin, M.D. to its board of directors, effective May 17, 2024. Dr. Amin, a highly...

2024-05-13 15:34:34 ET More on Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc (AVDL) Q1 2024 Earnings Call Transcript Avadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly Revolution Avadel Pharmaceuticals: Robust Launch Of Lumryz And Eased Litigation...

2024-05-10 15:29:27 ET More on Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc (AVDL) Q1 2024 Earnings Call Transcript Avadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly Revolution Avadel Pharmaceuticals: Robust Launch Of Lumryz And Eased Litigation...

2024-05-08 12:52:04 ET Avadel Pharmaceuticals plc (AVDL) Q1 2024 Earnings Conference Call May 08, 2024 08:30 am ET Company Participants Austin Murtagh - Director at Stern Investor Relations Gregory Divis - CEO Richard Kim - Chief Commercial Officer Thomas McH...